LFST · NASDAQ · STOCK
LifeStance Health Group (LFST) Stock Analysis
$12.43
52W $4.77 – $13.56
62/100
$4.82B
95.4
1.24
Is LFST Bullish or Bearish?
Bullish.
Innellis AI committee rates LifeStance Health Group, Inc. (LFST) Buy with a composite score of 62/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +12.92 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -7.08 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 61.1% yoy -- genuine top-line momentum. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Revenue growing 61.1% YoY -- genuine top-line momentum — Growth
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Low leverage (debt-to-equity 0.18) -- balance sheet can absorb a shock — Risk
Bear Case
- P/E of 93.8 is expensive by classic value standards — Value
- ROE of only 3.4% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical
- News sentiment is negative (-0.17 across 6 articles, 14d) — News
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
62/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 20%
of 192 Healthcare peers
Value Analyst
neutral
44
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 93.8 is expensive by classic value standards
Growth Analyst
bullish
83
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 61.1% YoY -- genuine top-line momentum
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.18) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
52
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.17 across 6 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score strengthened from 58.3 to 62.1.
- Conviction changed from moderate to contested.
- Committee agreement fell notably from 67% to 50%.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Risk Analyst.
Analyst-level changes:
- Risk Analyst: stance neutral->bullish; score 58->80 (+22).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
61.1
Neutral
MACD Histogram
-0.006
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.57
Inside Bands
Price vs Moving Averages
EMA 9
$12.16
Above
EMA 21
$12.22
Above
EMA 50
$11.93
Above
EMA 200
$9.56
Above
Fundamental Analysis
Valuation
58
Growth
94
Profitability
14
Financial Health
74
Cash Flow
70
Valuation
P/E Ratio
95.4×
P/B Ratio
3.22×
PEG Ratio
0.04
Dividend Yield
0.00%
52W High
$13.56
52W Low
$4.77
Quality & Growth
ROE
63.5%
ROA
43.8%
Gross Margin
3355.9%
Operating Margin
494.9%
Revenue Growth YoY
—
Debt / Equity
0.14
AI Fundamental Assessment
P/E ratio of 95.4 (rich relative to a 15-40x range); Price-to-book of 3.2x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.6%; Return on assets of 0.4%; Net margin of 3.2%; Gross margin of 33.6%; Current ratio of 1.38 (tight short-term liquidity); Debt-to-equity of 0.14; Free cash flow per share is positive (0.55); Most recent quarter beat estimates by 34.5%; 4 consecutive earnings beats; EPS growth accelerating (+33.3% -> +50.0% QoQ); Analyst estimates rising over recent quarters
Get the Full LFST Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →